Oruka Therapeutics, Inc.
ORKA나스닥Pharmaceutical PreparationsUS미국
30일 공시 수
4건
최근 2026.10.26
90일 내부자 순매수
-101억원
순매도
보유 기관 수
—
준비 중
다음 예정 이벤트
—
준비 중
총 12건
- US미국주요사항·수시공시중요도 낮음2026.10.268-K · Current report (Items 7.01, 8.01, 9.01)
Oruka Therapeutics, Inc.ORKA
8-K · 2026.10.26 21:00 KST
- US미국임원·주요주주 소유중요도 보통2026.10.204 · Statement of changes in beneficial ownership
Oruka Therapeutics, Inc.ORKA
Form 4 · 2026.10.20
- US미국임원·주요주주 소유중요도 보통2026.10.154 · Statement of changes in beneficial ownership
Oruka Therapeutics, Inc.ORKA
Form 4 · 2026.10.15
- US미국임원·주요주주 소유중요도 높음2026.10.134 · Statement of changes in beneficial ownership
Oruka Therapeutics, Inc.ORKA
Form 4 · 2026.10.13
- US미국임원·주요주주 소유중요도 높음2026.10.024 · Statement of changes in beneficial ownership
Oruka Therapeutics, Inc.ORKA
Form 4 · 2026.10.02
- US미국임원·주요주주 소유중요도 낮음2026.09.214 · Statement of changes in beneficial ownership
Oruka Therapeutics, Inc.ORKA
Form 4 · 2026.09.21
- US미국임원·주요주주 소유중요도 높음2026.09.214 · Statement of changes in beneficial ownership
Oruka Therapeutics, Inc.ORKA
Form 4 · 2026.09.21
- US미국임원·주요주주 소유중요도 보통2026.09.154 · Statement of changes in beneficial ownership
Oruka Therapeutics, Inc.ORKA
Form 4 · 2026.09.15
- US미국임원·주요주주 소유중요도 높음2026.09.154 · Statement of changes in beneficial ownership
Oruka Therapeutics, Inc.ORKA
Form 4 · 2026.09.15
- US미국임원·주요주주 소유중요도 보통2026.09.154 · Statement of changes in beneficial ownership
Oruka Therapeutics, Inc.ORKA
Form 4 · 2026.09.15